Erasca

ERASNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.260 B

$15.04 +1.83%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$124.5M

Loss-making

Shares outstanding

349,762,035

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#53Ptc TherapeuticsPTCT$5.45B
#54Dianthus TherapeuticsDNTH$5.40B
#55ErascaERAS$5.26B
#56GrifolsGRFS$5.06B
#57Edgewise TherapeuticsEWTX$4.85B

What if Erasca were worth as much as…

Open the what-if tool →

Gold $30.3T

$86,556.15

Per share 5,755× higher

Bitcoin $1.72T

$4,917.07

Per share 327× higher

Nvidia $5.48T

$15,667.39

Per share 1,042× higher

Or at a round number

$10.0B $20.0B $50.0B $100.0B

Where these numbers come from

Share counts and financials for Erasca are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.